- Home
- Services
- usa massachusetts
- genomic profile
Refine by
Genomic Profile Services In Usa Massachusetts
6 services found
Manufactured by:Foundation Medicine, Inc. based inCambridge, MASSACHUSETTS (USA)
Discover tissue AND blood-based FDA-approved comprehensive genomic profiling testing for all solid tumors with FoundationOne®CDx and FoundationOne®Liquid CDx. In addition, FoundationOne®Heme is a laboratory developed test for hematologic malignancies, sarcomas, or solid tumors where fusion detection is desired. ...
Manufactured by:Foundation Medicine, Inc. based inCambridge, MASSACHUSETTS (USA)
Ranging from interpretation of results on each report to expert consultations and ongoing education, these services can help you make the most of comprehensive genomic profiling (CGP) in your ...
Manufactured by:Foundation Medicine, Inc. based inCambridge, MASSACHUSETTS (USA)
Our genomic information knowledgebase is continuously evolving, informed by every clinical sample sequenced with Foundation Medicine’s comprehensive genomic profiling tests. You can also access a unique clinicogenomic data set through our partnership with Flatiron Health, a leading provider of clinical ...
Manufactured by:Foundation Medicine, Inc. based inCambridge, MASSACHUSETTS (USA)
Simplified test results provide information about genomic findings and biomarkers and their associated targeted therapies when available. We also provide information on clinically relevant alterations and available clinical trial options specific to each patient’s ...
Manufactured by:Foundation Medicine, Inc. based inCambridge, MASSACHUSETTS (USA)
Foundation Medicine matches patients to precision oncology trials based on genomic alterations, tumor type, and age. Our team of expert curators and genomicists helps facilitate awareness of genomically matched clinical trial options for your ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Unlocking the potential of precision medicine with Artificial Intelligence – enabled data-driven insights. Advance targeted therapy development by harnessing the power of data and multimodal analytics. Advances in molecular and imaging techniques have resulted in an explosion of data, providing an unprecedented opportunity to identify clinically relevant drug targets. Yet, deciphering and ...